Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
06/2004
06/16/2004CN1505526A Compositions and methods for wt1 specific immunotherapy
06/16/2004CN1504752A Vaughan Tristan J.
06/16/2004CN1504577A Process for producing L-methionine, aminoacylase strain and aminoacylase
06/16/2004CN1504575A Controlling method for expression system of T7 induced by laevorotary arabinose
06/16/2004CN1504574A Controlling T7 expression system by means of thermal induction
06/16/2004CN1504572A Expression of recombination FL protein in pichia yeast
06/16/2004CN1504567A Non-reducing saccharide-forming enzyme, trehalose-releasing enzyme, and process for producing saccharides using the same enzymes
06/16/2004CN1504565A Microorganism for producing riboflavin and method for producing riboflavin using the same
06/16/2004CN1504564A Microorganism for producing riboflavin and method for producing riboflavin using the same
06/16/2004CN1504563A Technology for producing high density silicate bacterium agent
06/16/2004CN1504562A YB microbe function fungus and domestic organic garbage treating machine
06/16/2004CN1504561A Method for preparing fermented nutrient solution using amino acid fermentation isoelectric supernatant and application thereof
06/16/2004CN1504440A Microorganism agricultural potassium fertilizer modified in plasma environment
06/16/2004CN1504439A Microorganism agricultural phosphate fertilizer modified in plasma environment
06/16/2004CN1504438A Microorganism agricultural fertilizer modified in plasma environment
06/16/2004CN1504109A Liquid containing diatom, diatom and method for culturing diatom
06/16/2004CN1153967C Method for measuring nitration/denitrification rate and Nox in liquid
06/16/2004CN1153831C Gene of encoding endoglycoceramidase activator
06/16/2004CN1153575C Pharmaceutical preparation comprising rhamnose lactobacillus
06/16/2004CN1153525C Parched potato, parched potato koji and method of manufacturing wine and food using the same
06/15/2004US6750382 DNA constructs and methods to impart resistance to papaya ringspot virus on plants
06/15/2004US6750334 Ctla4 (cd28-like which are t lymphocyte molec) used to suppress an immune response in the subject, for example to inhibit transplantation rejection, graft versus host disease or autoimmune response
06/15/2004US6750327 Compositions and method for determining the presence of human PTTG peptide in a sample
06/15/2004US6750323 Platelet activation protein
06/15/2004US6750322 Guanosine triphosphate (GTP) binding protein-coupled receptor proteins
06/15/2004US6750176 Comprising microorganisms which can be viable at a high survival rate over long periods and exhibit good physical properties during application
06/15/2004US6750056 Metal binding proteins and associated methods
06/15/2004US6750052 Lens epithelial cell derived growth factor
06/15/2004US6750051 Using enzyme isolated from orpinomyces
06/15/2004US6750048 Removing lipids from microorganism; lyse microorganism cells, separate mixture into phases, recover lipids from solution
06/15/2004US6750045 Fermentation medium and method
06/15/2004US6750040 By incubating appropriate substrate set; for making a library of polyketides
06/15/2004US6750034 Useful as therapeutic agents for cancer, skin disorders, neuropathic pain, inflammatory, or coagulation diathesis/thrombosis; may also be useful for laundry detergents and skin care products; derived from humans
06/15/2004US6750027 Enzymatic polypeptide for use in the treatment, diagnosis and prevention of cancer, autoimmune and nervous system disorders
06/15/2004US6750012 For identifying compounds that do not induce motor side effects
06/15/2004US6749858 Nucleotide sequences coding polypeptide for use in the prevention of streptoccocus infection
06/15/2004US6749855 Treating peripheral resistance in a mammal; modulating the immune response in a mammal
06/15/2004US6749848 Biological control of nematodes with Hirsutella minnesotensis
06/15/2004US6749809 Clustered creature exterminating method
06/10/2004WO2004048597A2 Composition and method for inhibition of microorganisms
06/10/2004WO2004048576A1 Phosphorylated ndr kinase
06/10/2004WO2004048574A1 Immunoreceptor proteins
06/10/2004WO2004048573A1 Mammalian prickle gene
06/10/2004WO2004048568A1 UTILIZATION OF mKank GENE IN CANTER THERAPY, CANER DETECTION AND DRUG DISCOVERY
06/10/2004WO2004048561A1 Enzymatic reaction system comprising a pqq-dependent alcohol dehydrogenase and a quinoid redox cofactor compound
06/10/2004WO2004048559A1 Metabolically engineered micro-organisms having reduced production of undesired metabolic products
06/10/2004WO2004048553A1 Liquid containing diatom, diatom and method for culturing diatom
06/10/2004WO2004048552A2 Modulating immune responses
06/10/2004WO2004048541A2 Cct6s as modifiers of the rb pathway and methods of use
06/10/2004WO2004048536A2 Rhebs as modifiers of the rb pathway and methods of use
06/10/2004WO2004048512A2 Novel proteins and nucleic acids encoding same
06/10/2004WO2004047812A1 Hollow nanoparticles of protein and drug using the same
06/10/2004WO2004047763A2 Production of ubiquinones
06/10/2004WO2004047740A2 Composition and method for treating lupus nephritis
06/10/2004WO2004047612A2 Methods of therapy and diagnosis
06/10/2004WO2004029278A3 Aav itr-mediated modulation
06/10/2004WO2004022720A8 Methods for identifying antimicrobial compounds
06/10/2004WO2004013343A3 Use of lactobacillus to produce exopolysaccharides in food and pharmaceutical compositions
06/10/2004WO2004013285A3 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
06/10/2004WO2004011647A8 Modified small interfering rna molecules and methods of use
06/10/2004WO2004003235A3 Probiotic strains, a process for the selection of them, compositions thereof, and their use
06/10/2004WO2003104470A3 Retrons for gene targeting
06/10/2004WO2003093424A9 In vivo ssdna expression vectors for altering gene expression
06/10/2004WO2003089571A3 Ehrlichia canis genes and vaccines
06/10/2004WO2003084472A3 Recombinant p. falciparum merozoite protein-142 vaccine
06/10/2004WO2003083039A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
06/10/2004WO2003068917A3 Functionalization of carotenoid compounds
06/10/2004WO2003066842A3 Method for producing recombinant proteins in micro-organisms
06/10/2004WO2003060128A3 Compositions, methods and systems for discovery of lipopeptides
06/10/2004WO2003054755A3 Vaccine for periodontal disease
06/10/2004WO2003054142A3 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase
06/10/2004WO2003048342A3 Liquid yeast compositions
06/10/2004WO2003040170A9 Antibodies to cd40
06/10/2004WO2003012121A3 Collagen xxii, a novel human collagen and uses thereof
06/10/2004WO2003007800A9 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer
06/10/2004US20040111769 Sugar beet genes involved in stress tolerance
06/10/2004US20040111764 expression cassette comprising promoter operably linked to a polynucleotide encoding a recombinational DNA repair polypeptide
06/10/2004US20040110935 Universal carrier for targeting molecules to Gb3 receptor expressing cells
06/10/2004US20040110934 Human mitochondrial proteins and polynucleotides encoding the proteins
06/10/2004US20040110921 Comprises chordin-like polypeptide fo diagnosis, pre vention and treatment of bone and cancer disorders; gene therapy; antitumor agents
06/10/2004US20040110920 Novel g protein-coupled receptor protein and dna thereof
06/10/2004US20040110919 Comprises toxic jellyfish protein for use as pesticide
06/10/2004US20040110715 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction
06/10/2004US20040110706 Nucleic acid with point mutations, deletions, insertions and/or rearrangements ; hyperthermia, myasthenia, ataxia, neuropathic and inflammatory pain; Alzheimer*s, Parkinson's disease; schizophrenia, hyperekplexia, myotonias and arrhythmia
06/10/2004US20040110677 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering
06/10/2004US20040110668 Nucleic acid sequences differentially expressed in cancer tissue
06/10/2004US20040110270 Bacterial composition and its use
06/10/2004US20040110269 Protection against mycobacterial infections
06/10/2004US20040110268 Attenuated Pasteurellaceae virulence genes are identified and used to screen bactericides and produce vaccines which prevent infection
06/10/2004US20040110267 Room temperature stable competent cells
06/10/2004US20040110262 Recombinant L-N-carbamoylase from Arthrobacter aurescens and method of producing L-amino acids therewith
06/10/2004US20040110261 Campylobacter nucleotide sequences coding transferase which modifies lipopolysaccharide for use in identifying agonist to infection; bactericides
06/10/2004US20040110260 Recombinant minimal catalytic vanadium haloperoxidases and their uses
06/10/2004US20040110257 Production of farnesol and geranylgeraniol
06/10/2004US20040110254 Method for producing alpha-1, 6-branched alph-1, 4-glucans from sucrose
06/10/2004US20040110252 Yeast-based assay
06/10/2004US20040110249 Microorganism for producing riboflavin and method for producing riboflavin using the same
06/10/2004US20040110248 Bacillus subtilis which is resistant to threonine analogue; high concentration in high yield
06/10/2004US20040110218 BMOG, a novel protein member of the myelin-oligodendrocyte glycoprotein family and its use for immunomodulatory purposes
06/10/2004US20040110210 Bacillus stearothermophilus SSB protein and use thereof